Commerzbank Aktiengesellschaft’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30M | Sell |
32,580
-4,645
| -12% | -$4.71M | 0.63% | 34 |
|
|
2025
Q4 | $40M | Sell |
37,225
-2,562
| -6% | -$2.45M | 0.81% | 29 |
|
|
2025
Q3 | $30.4M | Sell |
39,787
-741
| -2% | -$551K | 0.63% | 35 |
|
|
2025
Q2 | $31.6M | Sell |
40,528
-30
| -0.1% | -$23.3K | 0.72% | 29 |
|
|
2025
Q1 | $33.5M | Buy |
40,558
+31,915
| +369% | +$26.6M | 0.78% | 31 |
|
|
2024
Q4 | $6.67M | Buy |
8,643
+2,418
| +39% | +$2M | 0.16% | 59 |
|
|
2024
Q3 | $5.51M | Buy |
6,225
+1,971
| +46% | +$1.77M | 0.15% | 63 |
|
|
2024
Q2 | $3.85M | Buy |
4,254
+389
| +10% | +$311K | 0.13% | 65 |
|
|
2024
Q1 | $3.01M | Buy |
3,865
+959
| +33% | +$682K | 0.1% | 72 |
|
|
2023
Q4 | $1.69M | Buy |
2,906
+1,627
| +127% | +$950K | 0.07% | 72 |
|
|
2023
Q3 | $687K | Buy |
1,279
+370
| +41% | +$191K | 0.03% | 86 |
|
|
2023
Q2 | $426K | Buy |
909
+209
| +30% | +$87.6K | 0.02% | 100 |
|
|
2023
Q1 | $240K | Sell |
700
-12,790
| -95% | -$4.31M | 0.01% | 114 |
|
|
2022
Q4 | $4.93M | Sell |
13,490
-250
| -2% | -$88.6K | 0.31% | 37 |
|
|
2022
Q3 | $4.44M | Buy |
13,740
+2,000
| +17% | +$634K | 0.33% | 34 |
|
|
2022
Q2 | $3.81M | Buy |
11,740
+3,965
| +51% | +$1.19M | 0.27% | 36 |
|
|
2022
Q1 | $2.23M | Buy |
7,775
+350
| +5% | +$90.1K | 0.13% | 43 |
|
|
2021
Q4 | $2.05M | Buy |
7,425
+550
| +8% | +$139K | 0.12% | 46 |
|
|
2021
Q3 | $1.59M | Buy |
6,875
+5,750
| +511% | +$1.42M | 0.09% | 49 |
|
|
2021
Q2 | $258K | Hold |
1,125
| – | – | 0.02% | 60 |
|
|
2021
Q1 | $210K | Buy |
+1,125
| New | +$220K | 0.01% | 72 |
|
|
2020
Q2 | – | Sell |
-4,546
| Closed | -$631K | – | 278 |
|
|
2020
Q1 | $631K | Sell |
4,546
-17,644
| -80% | -$2.42M | 0.03% | 234 |
|
|
2019
Q4 | $2.92M | Sell |
22,190
-60,327
| -73% | -$6.99M | 0.03% | 278 |
|
|
2019
Q3 | $9.23M | Sell |
82,517
-525
| -0.6% | -$58.5K | 0.07% | 210 |
|
|
2019
Q2 | $9.2M | Sell |
83,042
-1,268
| -2% | -$149K | 0.07% | 203 |
|
|
2019
Q1 | $10.9M | Sell |
84,310
-2,069
| -2% | -$252K | 0.1% | 165 |
|
|
2018
Q4 | $10M | Sell |
86,379
-14,745
| -15% | -$1.65M | 0.1% | 165 |
|
|
2018
Q3 | $10.9M | Sell |
101,124
-5,527
| -5% | -$553K | 0.09% | 175 |
|
|
2018
Q2 | $9.1M | Sell |
106,651
-23,711
| -18% | -$1.95M | 0.09% | 192 |
|
|
2018
Q1 | $10.1M | Buy |
130,362
+22,035
| +20% | +$1.77M | 0.1% | 177 |
|
|
2017
Q4 | $9.15M | Sell |
108,327
-3,353
| -3% | -$285K | 0.11% | 178 |
|
|
2017
Q3 | $9.55M | Buy |
111,680
+7,106
| +7% | +$583K | 0.13% | 152 |
|
|
2017
Q2 | $8.61M | Sell |
104,574
-841
| -0.8% | -$68.6K | 0.14% | 134 |
|
|
2017
Q1 | $8.87M | Buy |
105,415
+34,482
| +49% | +$2.76M | 0.13% | 147 |
|
|
2016
Q4 | $5.22M | Sell |
70,933
-2,743
| -4% | -$204K | 0.08% | 211 |
|
|
2016
Q3 | $5.91M | Sell |
73,676
-15,278
| -17% | -$1.22M | 0.1% | 188 |
|
|
2016
Q2 | $7K | Buy |
88,954
+3,069
| +4% | +$231K | 0.05% | 192 |
|
|
2016
Q1 | $6.18M | Sell |
85,885
-27,634
| -24% | -$2.09M | 0.05% | 201 |
|
|
2015
Q4 | $9.56M | Buy |
113,519
+6,052
| +6% | +$502K | 0.07% | 194 |
|
|
2015
Q3 | $8.99M | Sell |
107,467
-78,825
| -42% | -$6.65M | 0.07% | 191 |
|
|
2015
Q2 | $15.6M | Sell |
186,292
-15,220
| -8% | -$1.16M | 0.08% | 159 |
|
|
2015
Q1 | $14.6M | Sell |
201,512
-61,798
| -23% | -$4.4M | 0.09% | 164 |
|
|
2014
Q4 | $18.2M | Sell |
263,310
-186,998
| -42% | -$12.6M | 0.12% | 147 |
|
|
2014
Q3 | $29.2M | Sell |
450,308
-9,555
| -2% | -$605K | 0.12% | 132 |
|
|
2014
Q2 | $28.6M | Sell |
459,863
-17,602
| -4% | -$1.05M | 0.15% | 119 |
|
|
2014
Q1 | $28.1M | Sell |
477,465
-39,095
| -8% | -$2.18M | 0.12% | 113 |
|
|
2013
Q4 | $27.9M | Sell |
516,560
-186,097
| -26% | -$9.32M | 0.14% | 106 |
|
|
2013
Q3 | $35.4M | Buy |
702,657
+21,121
| +3% | +$1.11M | 0.18% | 108 |
|
|
2013
Q2 | $33.5M | Buy |
+681,536
| New | +$37.1M | 0.15% | 123 |
|
Other funds holding LLY
VCM
VPM
Commerzbank Aktiengesellschaft's LLY Position: Q1 2026 in Review
Commerzbank Aktiengesellschaft reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $4.71M and leaving 32,580 shares worth $30M. The position accounts for 0.63% of the portfolio, ranked #34.
Commerzbank Aktiengesellschaft first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $40M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Commerzbank Aktiengesellschaft held 32,580 shares of Eli Lilly worth $30M as of Q1 2026.
- Commerzbank Aktiengesellschaft sold 4,645 Eli Lilly shares in Q1 2026, an estimated $4.71M.
- Eli Lilly made up 0.63% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #34 holding.
- Commerzbank Aktiengesellschaft first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
- Commerzbank Aktiengesellschaft's Eli Lilly position peaked at $40M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.